These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15095478)
1. Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma. Furuya M; Nishiyama M; Kimura S; Suyama T; Naya Y; Ito H; Nikaido T; Ishikura H J Pathol; 2004 May; 203(1):551-8. PubMed ID: 15095478 [TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas. Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051 [TBL] [Abstract][Full Text] [Related]
3. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685 [TBL] [Abstract][Full Text] [Related]
5. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma. Thelen P; Hemmerlein B; Kugler A; Seiler T; Ozisik R; Kallerhoff M; Ringert RH Anticancer Res; 1999; 19(2C):1563-5. PubMed ID: 10365146 [TBL] [Abstract][Full Text] [Related]
6. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry. Diegmann J; Junker K; Gerstmayer B; Bosio A; Hindermann W; Rosenhahn J; von Eggeling F Eur J Cancer; 2005 Aug; 41(12):1794-801. PubMed ID: 16043348 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel alternative splicing variant of RGS5 mRNA in human ocular tissues. Liang Y; Li C; Guzman VM; Chang WW; Evinger AJ; Sao D; Woodward DF FEBS J; 2005 Feb; 272(3):791-9. PubMed ID: 15670159 [TBL] [Abstract][Full Text] [Related]
8. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas. Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941 [TBL] [Abstract][Full Text] [Related]
9. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908 [TBL] [Abstract][Full Text] [Related]
10. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma. Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273 [TBL] [Abstract][Full Text] [Related]
12. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma. Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175 [TBL] [Abstract][Full Text] [Related]
13. The expression patterns of RGS transcripts in platelets. Kim SD; Sung HJ; Park SK; Kim TW; Park SC; Kim SK; Cho JY; Rhee MH Platelets; 2006 Nov; 17(7):493-7. PubMed ID: 17074726 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids. Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000 [TBL] [Abstract][Full Text] [Related]
15. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325 [TBL] [Abstract][Full Text] [Related]
16. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation. Wethkamp N; Ramp U; Geddert H; Schulz WA; Florl AR; Suschek CV; Hassan M; Gabbert HE; Mahotka C Eur J Cancer; 2006 Jan; 42(2):264-74. PubMed ID: 16386893 [TBL] [Abstract][Full Text] [Related]
17. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. Jung M; Ramankulov A; Roigas J; Johannsen M; Ringsdorf M; Kristiansen G; Jung K BMC Mol Biol; 2007 Jun; 8():47. PubMed ID: 17559644 [TBL] [Abstract][Full Text] [Related]
18. Regulator of G protein signaling 5 marks peripheral arterial smooth muscle cells and is downregulated in atherosclerotic plaque. Li J; Adams LD; Wang X; Pabon L; Schwartz SM; Sane DC; Geary RL J Vasc Surg; 2004 Sep; 40(3):519-28. PubMed ID: 15337883 [TBL] [Abstract][Full Text] [Related]
19. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers. Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938 [TBL] [Abstract][Full Text] [Related]
20. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma. Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]